Overview

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Vortioxetine (Lu AA21004), once daily (QD), compared with escitalopram on sexual functioning.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Citalopram
Dexetimide
Serotonin Uptake Inhibitors
Vortioxetine